Delivery Order SPE2DB20D1109-SPE2DB24FN02J
- Not listed
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,323.40, is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGE medication. The contract is a Firm Fixed Price, non-set-aside award with an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation (AmerisourceBergen) for the supply of Havrix 1,440 unit/mL syringes. The contract has a ceiling value of $1,524.40 and is a firm fixed-price contract. AmerisourceBergen is a major pharmaceutical distributor that has been awarded numerous federal contracts to supply a wide range of medical and pharmaceutical products to the U.S. government. This contract does not have a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of HAVRIX 1,440 UNIT/ML SYRINGEML, a vaccine product. The contract has a firm fixed price of $7,391.70 and a completion date of January 28, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Havrix 720 unit/0.5 mL syringes. The contract has a firm fixed price of $1,521.21 and a period of performance from May 15, 2024 to May 16, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Havrix 1,440 unit/mL syringes. The contract, valued at $2,109.27, is a firm fixed-price delivery order with a completion date of May 28, 2024. AmerisourceBergen, a major pharmaceutical distributor, has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is not set-aside, has a ceiling value of $17,431.75 and covers the delivery of HAVRIX 1,440 unit/mL syringes through December 30, 2024. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, that...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HAVRIX 720 Unit/0.5 ML syringes, a vaccine product, with a total ceiling value of $1,012.20. The contract is a firm fixed-price, non-set-aside agreement with a performance period through May 7, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Havrix 1,440 unit/mL syringes. The award, worth $3,667.40, has a firm-fixed price and an ultimate completion date of March 2, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, including the Department of Defense and Department of...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,110.37, is for the delivery of Havrix 1,440 unit/mL syringes. The ultimate completion date for this contract is August 2, 2024. This contract award is not associated with any set-aside program and is part of Amerisourcebergen's extensive portfolio of federal contracts, including an...
- This is a delivery order award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,925.10 firm fixed-price contract is for the delivery of HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML pharmaceutical products, with a completion date of December 18, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB24FN02JDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $36,674.00, is for the delivery of Havrix 1,440 unit/mL syringes. The contract has a firm fixed price and is set to complete by November 6, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as the primary vehicle for AmerisourceBergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $36.7k | 11/3/23 |